RedHill Biopharma (RDHL) Enterprise Value (2011 - 2025)
RedHill Biopharma (RDHL) reported Enterprise Value of -$4.0 million for Q4 2025, up 34.23% year-over-year from -$3.0 million in Q4 2024, and up 14.2% quarter-over-quarter from -$4.6 million in Q2 2025.
RedHill Biopharma (RDHL) Enterprise Value (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has 15 years of Enterprise Value data on file, last reported at -$4.0 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$4.0 million, up 34.23% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.0 million (up 34.23% YoY), and the FY2025 annual result was -$4.0 million, up 34.23% from the prior year.
- Enterprise Value rose to -$4.0 million in Q4 2025 per RDHL's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$4.0 million in Q4 2025 and troughed at -$51.8 million in Q2 2021.
- A 5-year average of -$21.4 million and a median of -$22.6 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2023: Enterprise Value tumbled 132.65% in 2021, then jumped 72.07% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$29.5 million in 2021, then grew by 23.35% to -$22.6 million in 2022, then jumped by 72.07% to -$6.3 million in 2023, then gained by 4.31% to -$6.0 million in 2024, then jumped by 34.23% to -$4.0 million in 2025.
- Business Quant data shows RDHL's Enterprise Value at -$4.0 million in Q4 2025, -$4.6 million in Q2 2025, and -$6.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | -3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.97 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -6.04 Mn |
| Jun 30, 2024 | -8.11 Mn |
| Dec 31, 2023 | -6.31 Mn |
| Jun 30, 2023 | -21.60 Mn |
| Mar 31, 2023 | -19.20 Mn |
| Dec 31, 2022 | -22.59 Mn |
| Sep 30, 2022 | -32.41 Mn |
| Jun 30, 2022 | -33.06 Mn |
| Mar 31, 2022 | -29.47 Mn |
| Dec 31, 2021 | -29.47 Mn |
| Sep 30, 2021 | -23.25 Mn |
| Jun 30, 2021 | -51.82 Mn |
| Mar 31, 2021 | -29.30 Mn |
| Dec 31, 2020 | -29.30 Mn |
| Sep 30, 2020 | -29.02 Mn |
| Jun 30, 2020 | -22.27 Mn |
| Mar 31, 2020 | -81.61 Mn |
| Dec 31, 2019 | -29.02 Mn |